Ideas
RNA therapy names bottoming, rebound possible
RNA therapy biotech stocks Olix Pharmaceuticals and Rznomics have given back all their early-year gains and are now showing strong bottoming signals with rebounds emerging, suggesting the worst may be over and a bounce is underway.
5-day correction is buying opportunity
Today’s decline in Korean semiconductor equipment stocks like HPSP and Wonik IPS is merely a 5-day moving average correction after strong gains, with no negative fundamental news. The pullback presents a buying opportunity within the ongoing uptrend.
Boston Dynamics stake could trigger re-rating
If Samsung Electronics acquires a stake in Boston Dynamics from SoftBank, it could open a re-rating path for the stock as a new business play, though Samsung has denied the report. The rumor is worth monitoring because any confirmation would change the valuation narrative.
ADR and Nasdaq 100 catalyst incoming
SK Hynix’s planned ADR listing (approx. 40 trillion won) and the possibility of fast-track inclusion in the Nasdaq 100 could trigger heavy ETF buying, creating a short-term supply/demand catalyst and re-rating potential. The stock has already broken out to new highs and the ADR approval is expected next week.
Wind ban ruled unconstitutional, CS Wind cheap
A U.S. federal court ruled Trump's wind power ban unconstitutional, directly benefiting CS Wind which has a factory in the U.S. The stock is cheap (<10x PE), earnings are solid, and the legal victory opens up growth that had been blocked; while short-term profit-taking is possible, the mid/long-term outlook is positive.
European JV unlocks durable defense rally
LIG Nex1’s joint venture with Rheinmetall to enter the European missile market is a game-changer, accelerating growth and providing sustained foreign buying. The stock is still only 22x PE, with analysts raising targets, and the defense sector as a whole is benefiting from post-war rebuilding demand; the rally is sustainable.
Reconstruction theme overhyped, avoid these stocks
Daewoo E&C and Hyundai E&C are unlikely to benefit materially from Middle East reconstruction because oil-producing nations have limited cash after reduced oil sales and ongoing welfare spending. The recent bounce is just a trading bounce, not a breakout; only trade them, do not invest.
SMR law passage pushes nuclear rally
The special SMR law will be enacted on the 18th, providing a clear catalyst for nuclear power stocks. Doosan Enerbility, the sector leader, will rally again as the regulatory overhang clears.
HL Mando cheaper, better robot play
HL Mando is a cheaper and fundamentally solid robot thermal management play compared to Hanon Systems. With a target price around 100,000 KRW and still discounted valuation, it offers a better risk/reward for the humanoid robot theme, supported by recent analyst reports and foreign buying.
MLCC super-cycle justifies high multiple
Samsung Electro-Mechanics is in a structural MLCC super-cycle driven by AI servers (12,000 MLCCs per board vs 6,000 before), automotive, and smartphones. The company’s 50x P/E is justified by this shift, and the stock should continue to trend higher even if short-term overbought; the FCBGA/silicon capacitor bundling adds value.
This 3PRO TV (삼프로TV) video, published June 16, 2026,
features Lee Kwon-hee, Kim Jang-yeol
discussing 226950.KQ, 217500.KQ, 403870.KQ, 240810.KQ, 005930.KS, 000660.KS, 112610.KS, 079550.KS, 047040.KS, 000720.KS, 034020.KS, 204320.KS, 009150.KS.
10 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Kwon-hee,
Kim Jang-yeol
· Tickers:
226950.KQ,
217500.KQ,
403870.KQ,
240810.KQ,
005930.KS,
000660.KS,
112610.KS,
079550.KS,
047040.KS,
000720.KS,
034020.KS,
204320.KS,
009150.KS